These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 12163821)

  • 1. The imbalance between tissue factor and tissue factor pathway inhibitor in sepsis.
    Levi M
    Crit Care Med; 2002 Aug; 30(8):1914-5. PubMed ID: 12163821
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological inhibition of tissue factor.
    Laterre PF; Wittebole X; Collienne C
    Semin Thromb Hemost; 2006 Feb; 32(1):71-6. PubMed ID: 16479464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue factor production not balanced by tissue factor pathway inhibitor in sepsis promotes poor prognosis.
    Gando S; Kameue T; Morimoto Y; Matsuda N; Hayakawa M; Kemmotsu O
    Crit Care Med; 2002 Aug; 30(8):1729-34. PubMed ID: 12163784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue factor pathway inhibitor activity in severe sepsis.
    Creasey AA; Reinhart K
    Crit Care Med; 2001 Jul; 29(7 Suppl):S126-9. PubMed ID: 11445747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolving role of tissue factor and its pathway inhibitor.
    Doshi SN; Marmur JD
    Crit Care Med; 2002 May; 30(5 Suppl):S241-50. PubMed ID: 12004243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue factor as a therapeutic target in coronary syndromes.
    Banai S; Gertz SD
    Am J Cardiol; 2001 Mar; 87(6):763-5. PubMed ID: 11249899
    [No Abstract]   [Full Text] [Related]  

  • 7. TFPI-dependent activities of protein S.
    Peraramelli S; Rosing J; Hackeng TM
    Thromb Res; 2012 May; 129 Suppl 2():S23-6. PubMed ID: 22425215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor inhibition and clinical trial results of tissue factor pathway inhibitor in sepsis.
    Abraham E
    Crit Care Med; 2000 Sep; 28(9 Suppl):S31-3. PubMed ID: 11007194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue factor pathway inhibitor and antithrombin trial results.
    LaRosa SP; Opal SM
    Crit Care Clin; 2005 Jul; 21(3):433-48. PubMed ID: 15992666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probable regulation of factor VIIa-tissue factor and prothrombinase by factor Xa-TFPI and TFPI in vivo.
    Gouin-Thibault I; Dewar L; Craven S; Kulczycky M; Wun TC; Ofosu FA
    Br J Haematol; 1996 Dec; 95(4):738-46. PubMed ID: 8982054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of LDL-associated tissue factor pathway inhibitor.
    Augustsson C; Hilden I; Petersen LC
    Thromb Res; 2014 Jul; 134(1):132-7. PubMed ID: 24787991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factor pathway inhibitor: potential therapeutic applications.
    Bajaj MS; Bajaj SP
    Thromb Haemost; 1997 Jul; 78(1):471-7. PubMed ID: 9198199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor.
    Tang H; Ivanciu L; Popescu N; Peer G; Hack E; Lupu C; Taylor FB; Lupu F
    Am J Pathol; 2007 Sep; 171(3):1066-77. PubMed ID: 17640967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor and tissue factor pathway inhibitor in kidney allograft recipients.
    Malyszko JS; Malyszko J; Mysliwiec M
    Transplant Proc; 1999 Aug; 31(5):2118-20. PubMed ID: 10455987
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of tissue factor pathway inhibitor (TFPI) in thrombotic complications].
    Gosk-Bierska I; Adamiec R
    Pol Arch Med Wewn; 2005 Aug; 114(2):792-8. PubMed ID: 16808319
    [No Abstract]   [Full Text] [Related]  

  • 16. The Levels of Tissue Factor Pathway Inhibitor in Sepsis Patients Receiving Prophylactic Enoxaparin.
    Al Otair HA; Abdel Gader AG; Khurshid SM; Alzeer AH; Al Momen AK; Al Shaikh M; Al Gahtani F; Al Aseri ZA; Abdelrazik HA
    Turk J Haematol; 2016 Jun; 33(2):112-8. PubMed ID: 26377606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical trials for severe sepsis/DIC].
    Kushimoto S
    Rinsho Byori; 2011 Feb; Suppl 147():85-94. PubMed ID: 21761754
    [No Abstract]   [Full Text] [Related]  

  • 18. [The role of tissue factor and its inhibitor in hemostasis].
    Naumnik B; Małyszko J; Myśliwiec M
    Przegl Lek; 1998; 55(2):68-73. PubMed ID: 9695646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of tissue factor and tissue factor pathway inhibitor in health and disease states.
    DelGiudice LA; White GA
    J Vet Emerg Crit Care (San Antonio); 2009 Feb; 19(1):23-9. PubMed ID: 19691583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tissue factor and tissue factor pathway inhibitor in porcine endothelium in response to natural antibody and complement.
    Nagayasu T; Saadi S; Holzknecht RA; Miyata Y; Plummer TB; Platt JL
    Transplant Proc; 2001; 33(1-2):788. PubMed ID: 11267072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.